All In Biotech

Free tool

FAERS Monitor: Oxbryta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213137 or its brand name (Oxbryta, Voxelotor). Reports on generic versions are filed under their own applications.

Reports

22,311

Serious

9,624

43% of reports

Hospitalization

7,860

Death reported

419

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • sickle cell anaemia with crisis11,220
  • product dose omission issue5,172
  • diarrhoea3,187
  • off label use2,419
  • nausea2,017
  • headache1,691
  • abdominal pain upper1,171
  • pain1,086
  • therapy cessation1,040
  • fatigue1,008
  • abdominal discomfort970
  • therapy interrupted901
  • vomiting833
  • haemoglobin decreased753
  • abdominal pain627

Reports by year received

View as table
YearReports
20193
20203,384
20213,536
20229,276
20234,504
20241,436
2025142
202630

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,031,848 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sickle cell anaemia with crisisSignal11,2202322.02249.27,521,204
therapy cessationSignal1,04019.518.317,882
product dose omission issueSignal5,17216.916.576,861
therapy interruptedSignal90112.011.39,012
haemoglobin decreasedSignal7537.06.53,825
abdominal discomfortSignal9705.55.13,553
abdominal pain upperSignal1,1715.45.14,196
diarrhoeaSignal3,1874.74.59,440
off label useSignal2,4192.62.52,496
headacheSignal1,6912.52.41,631
abdominal painSignal6272.52.4591
nauseaSignal2,0172.42.31,716
vomiting8331.71.6229
pain1,0861.71.6298
fatigue1,0081.21.142

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.